Formación científica

Pediatric patient: Does the ideal target in UC treatment exist?

Unique considerations when treating children and adolescents with IBD include attention to the effects and risks of the treatments on growth and development, bone health, and psychosocial functioning. New alternatives of treatment still are needed in this context for safer and longer outcomes.

15 de septiembre, 2021

aprox. 2:30 h

Unique considerations when treating children and adolescents with IBD include attention to the effects and risks of the treatments on growth and development, bone health, and psychosocial functioning. New alternatives of treatment still are needed in this context for safer and longer outcomes.

The benefits of using steroids, immunosuppressants or biologics need to be carefully weighed against the risks: effects of the treatments on growth and development, bone health, and psychosocial functioning. Taken together, novel therapeutic approaches that will demonstrate adequate efficacy combined with acceptable safety profiles are continually needed.

This high-level medical e-learning course with Spanish leading experts in Immunology and IBD management will discuss if it is possible a promise of better and safer long-term outcomes compared with current approaches and which could be the role of Adacolumn in this special population.

ContáctanosPara solicitar información adicional

Contáctanos